Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer. | Cancer Sci | 2020 | 31958182 | PubTator, text mining | PubMed |
| Molecular regulation of TLR signaling in health and disease: mechano-regulation of macrophages and TLR signaling. | Innate Immun | 2020 | 31955624 | PubTator, text mining | PubMed |
| Investigation of eluted characteristics of fulvic acids using differential spectroscopy combined with Gaussian deconvolution and spectral indices. | Environ Sci Pollut Res Int | 2020 | 31953759 | PubTator, text mining | PubMed |
| Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. | J Clin Immunol | 2020 | 31953710 | PubTator, text mining | PubMed |
| Meta-Modal Information Flow: A Method for Capturing Multimodal Modular Disconnectivity in Schizophrenia. | IEEE Trans Biomed Eng | 2020 | 31944934 | PubTator, text mining | PubMed |
| Mitochondrial DNA variations and mitochondrial dysfunction in Fanconi anemia. | PLoS One | 2020 | 31940411 | PubTator, text mining | PubMed |
| Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels. | Sci Rep | 2020 | 31937788 | PubTator, text mining | PubMed |
| Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer. | High Throughput | 2020 | 31936873 | PubTator, text mining | PubMed |
| The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments. | Cancers (Basel) | 2020 | 31936627 | PubTator, text mining | PubMed |
| IL10 rs1800872 Is Associated with Non-Steroidal Anti-Inflammatory Drugs Exacerbated Respiratory Disease in Mexican-Mestizo Patients. | Biomolecules | 2020 | 31936183 | PubTator, text mining | PubMed |
| Implementation and use of whole exome sequencing for metastatic solid cancer. | EBioMedicine | 2020 | 31923800 | PubTator, text mining | PubMed |
| Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort. | Cancer | 2020 | 31923330 | PubTator, text mining | PubMed |
| Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance. | Mini Rev Med Chem | 2020 | 31902358 | PubTator, text mining | PubMed |
| Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia. | J Clin Invest | 2020 | 31877112 | PubTator, text mining | PubMed |
| Allosteric mechanism for site-specific ubiquitination of FANCD2. | Nat Chem Biol | 2020 | 31873223 | PubTator, text mining | PubMed |
| Controlled saturation magnetization transfer for reproducible multivendor variable flip angle T1 and T2 mapping. | Magn Reson Med | 2020 | 31846122 | PubTator, text mining | PubMed |
| Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma. | Genet Med | 2020 | 31844177 | PubTator, text mining | PubMed |
| DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures. | Pac Symp Biocomput | 2020 | 31797602 | PubTator, text mining | PubMed |
| Investigations of Albumin-Insulin Detemir Complexes Using Molecular Dynamics Simulations and Free Energy Calculations. | Mol Pharm | 2020 | 31790268 | PubTator, text mining | PubMed |
| CD28 and CD57 define four populations with distinct phenotypic properties within human CD8+ T cells. | Eur J Immunol | 2020 | 31755098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=60